OncoFactory is a biotech offering unique, innovative and predictive patient-derived xenograft models in oncology
We replicate patient tumors in a fast and powerful in vivo model, suited for all types of cancers. This enables the evaluation of the efficacy of your drug candidates on tumors representative of the population of patients. It also allows developping biomarker programs.
Take advantage of our services for:
– Discovery and early screening
– Preclinical efficacy and lead validation
– Translational biomarker Discovery
– Mimic of conditions of clinical trials
– Characterization of the mode of action of your candidate molecules
Cancer types successfully replicated in our model:
Breast cancer
Melanoma
Prostate cancer
Pancreatic cancer
Lung cancer
Liver cancer
Glioma
Glioblastoma
Neuroblastoma
Germ Cell tumor
Oncofactory can design custom-made models and experimental programs adapted to the needs and specifities of clients. Please contact us to discuss your project.
Events
OncoFactory laureate of the 2nd Lyonbiopôle / HCL Clinical Innovation Call
Apicil supports OncoFactory
Scientific papers
Selected publications of the scientific founders since 2010
